📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Immune System's Contribution to the Clinical Efficacy of EGFR Antagonist Treatment. (2017)

First Author: MacDonald F

Attributed to: Use of EGF-R antagonists for the treatment of infections and tumour growth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2017.00575

PubMed Identifier: 28970798

Publication URI: http://europepmc.org/abstract/MED/28970798

Type: Journal Article/Review

Volume: 8

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812